Male predominance in AML is associated with specific preleukemic mutations

Aviv De-Morgan, Manja Meggendorfer, Claudia Haferlach, Liran Shlush*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

25 Citations (Scopus)

Abstract

NA
Original languageEnglish
Pages (from-to)867-870
Number of pages4
JournalLeukemia
Volume35
Issue number3
Early online date23 Jun 2020
DOIs
Publication statusPublished - Mar 2021

Funding

This research was supported by the EU horizon 2020 grant project MAMLE ID: 714731, LLS Grant ID: RTF6005-19, IMOS-712843, ISF IPMP grant ID 3165/19 and ISF-NSF grant ID 2427/18 awarded to LIS. LIS is an incumbent of the Ruth and Louis Leland career development chair. N.K. is an incumbent of the Applebaum Foundation Research Fellow Chair. This research was also supported by the Sagol Institute for Longevity Research, the Barry and Eleanore Reznik Family Cancer Research Fund, Steven B. Rubenstein Research Fund for Leukemia and Other Blood Disorders, the Rising Tide Foundation and the Applebaum Foundation. This work was supported by the Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine supporting LIS. Contributions - ADM designed the study, analyzed data, and wrote the paper, MM analyzed data, CH analyzed data, LIS designed the study, wrote the paper, and oversaw the research.

Fingerprint

Dive into the research topics of 'Male predominance in AML is associated with specific preleukemic mutations'. Together they form a unique fingerprint.

Cite this